These elevated inflammatory marker values, together with a decrease in TT as an antioxidant defence in the human body, lymphocytes and the pro-fibrotic factor TGF-β, may lead to increased mortality in hospitalised COVID-19 patients; TT, ferritin and LDH are shown to be the best markers for predicting disease severity. This evidence concerns the gene TGFB1 and COVID-19.